Daily Archives: 24, September 2021

Continental’s strong position in the segment of tires for all-electric vehicles has been underscored by Porsche Taycan approval

Porsche Taycan available with Continental summer, winter and all-season tires Original equipment approvals for PremiumContact 6, WinterContact TS 860 S and ProContact RX tires Continental Supplies Tires for Six of the Ten Most Successful Manufacturers of Electric Vehicles (PRESS RELEASE) … Read the full press release

Ernst & Young LLP (EY US) to develop GRC, cybersecurity, third-party risk management (TPRM) and risk transformation as a service (RTaaS) solutions supported by RSA’s Archer platform

Alliance will help EY US and RSA clients establish and enhance robust governance, risk and compliance strategies Leverages industry-leading Archer suite and EY US consulting services to provide integrated risk management solutions (PRESS RELEASE) LONDON, 24-Sep-2021 — /EuropaWire/ — EY, … Read the full press release

SGS’s metallurgical laboratory in Lakefield, Ontario, Canada, marks its 80th anniversary

(PRESS RELEASE) GENEVA, 24-Sep-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced that its metallurgical laboratory in Lakefield, Ontario, Canada celebrates 80 Years since inception. For 80 years the Lakefield laboratory in Ontario, Canada … Read the full press release

AstraZeneca: Exciting ROpel Phase III trial results demonstrate the potential for Lynparza with abiraterone to become a new 1st-line option for patients with metastatic castration-resistant prostate cancer

(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release

Spinal muscular atrophy: New data for Evrysdi will be presented by Roche at the World Muscle Society (WMS) Virtual Congress 20 – 24 September 2021

New data show pre-symptomatic babies with spinal muscular atrophy (SMA) treated with Evrysdi maintained the ability to swallow Evrysdi has demonstrated consistent clinically meaningful efficacy in adults, children, and babies two months and older and is now approved in 58 countries worldwide Further … Read the full press release